{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:59:09Z","timestamp":1790488749904,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1114-z","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T12:49:27Z","timestamp":1455281367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria"],"prefix":"10.1186","volume":"15","author":[{"given":"Tiphaine","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Dormoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylin","family":"Madamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"1114_CR1","unstructured":"WHO. World malaria report. Geneva: World Health Organization; 2014."},{"key":"1114_CR2","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.46.8.2315-2320.2002","volume":"46","author":"B Lell","year":"2002","unstructured":"Lell B, Kremsner PG. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother. 2002;46:2315\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/429343","volume":"191","author":"MW Dunne","year":"2005","unstructured":"Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, et al. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis. 2005;191:1582\u20138.","journal-title":"J Infect Dis"},{"key":"1114_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1475-2875-7-255","volume":"7","author":"RM Chico","year":"2008","unstructured":"Chico RM, Pittrof R, Greenwood B, Chandramohan D. Azithromycin\u2013chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J. 2008;7:255.","journal-title":"Malar J"},{"key":"1114_CR5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0035-9203(01)90106-3","volume":"95","author":"R McGready","year":"2001","unstructured":"McGready R, Cho T, Samuel S, Villegas L, Brockman A, van Vugt M, et al. Randomized comparison of quinine\u2013clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg. 2001;95:651\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1114_CR6","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/424603","volume":"190","author":"S Borrmann","year":"2004","unstructured":"Borrmann S, Issifou S, Esser G, Adegnika AA, Ramharter M, Matsiegui P-B, et al. Fosmidomycin\u2013clindamycin for the treatment of Plasmodium falciparum malaria. J Infect Dis. 2004;190:1534\u201340.","journal-title":"J Infect Dis"},{"key":"1114_CR7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/430309","volume":"40","author":"M Ramharter","year":"2005","unstructured":"Ramharter M, Oyakhirome S, Klein Klouwenberg P, Ad\u00e9gnika AA, Agnandji ST, Missinou MA, et al. Artesunate\u2013clindamycin versus quinine\u2013clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis. 2005;40:1777\u201384.","journal-title":"Clin Infect Dis"},{"key":"1114_CR8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1371\/journal.pone.0001166","volume":"2","author":"L Kalilani","year":"2007","unstructured":"Kalilani L, Mofolo I, Chaponda M, Rogerson SJ, Alker AP, Kwiek JJ, et al. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine\u2013pyrimethamine as treatment for malaria in pregnant women. PLoS One. 2007;2:1166.","journal-title":"PLoS One"},{"key":"1114_CR9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/605635","volume":"49","author":"A Sykes","year":"2009","unstructured":"Sykes A, Hendriksen I, Mtove G, Mandea V, Mrema H, Rutta B, et al. Azithromycin plus artesunate versus artemether\u2013lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. Clin Infect Dis. 2009;49:1195\u2013201.","journal-title":"Clin Infect Dis"},{"key":"1114_CR10","doi-asserted-by":"crossref","first-page":"42284","DOI":"10.1371\/journal.pone.0042284","volume":"7","author":"MK Laufer","year":"2012","unstructured":"Laufer MK, Thesing PC, Dzinjalamala FK, Nyirenda OM, Masonga R, Laurens MB, et al. A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone\u2013proguanil to treat malaria. PLoS One. 2012;7:42284.","journal-title":"PLoS One"},{"key":"1114_CR11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/1475-2875-13-458","volume":"13","author":"I Sagara","year":"2014","unstructured":"Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, et al. Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults. Malar J. 2014;13:458.","journal-title":"Malar J"},{"issue":"Suppl C","key":"1114_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/31.suppl_C.1","volume":"31","author":"T Mazzei","year":"1993","unstructured":"Mazzei T, Mini E, Novelli A, Periti P. Chemistry and mode of action of macrolides. J Antimicrob Chemother. 1993;31(Suppl C):1\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1114_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/514619","volume":"27","author":"C Carbon","year":"1998","unstructured":"Carbon C. Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens. Clin Infect Dis. 1998;27:28\u201332.","journal-title":"Clin Infect Dis"},{"key":"1114_CR14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/AAC.01825-12","volume":"57","author":"CD Goodman","year":"2013","unstructured":"Goodman CD, Useglio M, Peir\u00fa S, Labadie GR, McFadden GI, Rodr\u00edguez E, et al. Chemobiosynthesis of new antimalarial macrolides. Antimicrob Agents Chemother. 2013;57:907\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/106002809202601014","volume":"26","author":"CH Ballow","year":"1992","unstructured":"Ballow CH, Amsden GW. Azithromycin: the first azalide antibiotic. Ann Pharmacother. 1992;26:1253\u201361.","journal-title":"Ann Pharmacother"},{"key":"1114_CR16","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1074\/jbc.M608615200","volume":"282","author":"ABS Sidhu","year":"2007","unstructured":"Sidhu ABS, Sun Q, Nkrumah LJ, Dunne MW, Sacchettini JC, Fidock DA. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J Biol Chem. 2007;282:2494\u2013504.","journal-title":"J Biol Chem"},{"key":"1114_CR17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.1992.47.378","volume":"47","author":"BA Gingras","year":"1992","unstructured":"Gingras BA, Jensen JB. Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg. 1992;47:378\u201382.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","volume":"143","author":"MJ Parnham","year":"2014","unstructured":"Parnham MJ. Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014;143:225\u201345.","journal-title":"Pharmacol Ther"},{"issue":"Suppl B","key":"1114_CR19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/20.suppl_B.81","volume":"20","author":"OG Nilsen","year":"1987","unstructured":"Nilsen OG. Comparative pharmacokinetics of macrolides. J Antimicrob Chemother. 1987;20(Suppl B):81\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"1114_CR20","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/infdis\/158.6.1368","volume":"158","author":"PG Kremsner","year":"1988","unstructured":"Kremsner PG, Zotter GM, Feldmeier H, Graninger W, Rocha RM, Wiedermann G. A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil. J Infect Dis. 1988;158:1368\u201371.","journal-title":"J Infect Dis"},{"key":"1114_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.2002.67.54","volume":"67","author":"JE Touze","year":"2002","unstructured":"Touze JE, Heno P, Fourcade L, Deharo JC, Thomas G, Bohan S, et al. The effects of antimalarial drugs on ventricular repolarization. Am J Trop Med Hyg. 2002;67:54\u201360.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2003.11.003","volume":"484","author":"M Traebert","year":"2004","unstructured":"Traebert M, Dumotier B, Meister L, Hoffmann P, Dominguez-Estevez M, Suter W. Inhibition of hERG K\u00a0+\u00a0currents by antimalarial drugs in stably transfected HEK293 cells. Eur J Pharmacol. 2004;484:41\u20138.","journal-title":"Eur J Pharmacol"},{"key":"1114_CR23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4269\/ajtmh.2007.77.929","volume":"77","author":"AA Fossa","year":"2007","unstructured":"Fossa AA, Wisialowski T, Duncan JN, Deng S, Dunne M. Azithromycin\/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig. Am J Trop Med Hyg. 2007;77:929\u201338.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR24","first-page":"241","volume":"4","author":"RI Aminov","year":"2013","unstructured":"Aminov RI. Biotic acts of antibiotics. Front Microbiol. 2013;4:241.","journal-title":"Front Microbiol"},{"key":"1114_CR25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/138945008786786073","volume":"9","author":"T Fleige","year":"2008","unstructured":"Fleige T, Soldati-Favre D. Targeting the transcriptional and translational machinery of the endosymbiotic organelle in apicomplexans. Curr Drug Targets. 2008;9:948\u201356.","journal-title":"Curr Drug Targets"},{"key":"1114_CR26","doi-asserted-by":"crossref","first-page":"e1001138","DOI":"10.1371\/journal.pbio.1001138","volume":"9","author":"E Yeh","year":"2011","unstructured":"Yeh E, DeRisi JL. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 2011;9:e1001138.","journal-title":"PLoS Biol"},{"key":"1114_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbiopara.2007.01.005","volume":"152","author":"CD Goodman","year":"2007","unstructured":"Goodman CD, Su V, McFadden GI. The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol. 2007;152:181\u201391.","journal-title":"Mol Biochem Parasitol"},{"key":"1114_CR28","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/AAC.45.6.1746-1750.2001","volume":"45","author":"B Pradines","year":"2001","unstructured":"Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Barret E, et al. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob Agents Chemother. 2001;45:1746\u201350.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR29","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/AAC.39.7.1530","volume":"39","author":"ME Fichera","year":"1995","unstructured":"Fichera ME, Bhopale MK, Roos DS. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrob Agents Chemother. 1995;39:1530\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR30","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.bmc.2011.01.030","volume":"19","author":"A Hutinec","year":"2011","unstructured":"Hutinec A, Rup\u010di\u0107 R, Ziher D, Smith KS, Milhous W, Ellis W, Ohrt C, et al. An automated, polymer-assisted strategy for the preparation of urea and thiourea derivatives of 15-membered azalides as potential antimalarial chemotherapeutics. Bioorg Med Chem. 2011;19:1692\u2013701.","journal-title":"Bioorg Med Chem"},{"key":"1114_CR31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/jm201615t","volume":"55","author":"M Peri\u0107","year":"2012","unstructured":"Peri\u0107 M, Fajdeti\u0107 A, Rup\u010di\u0107 R, Alihod\u017ei\u0107 S, Ziher D, Bukvi\u0107 Kraja\u010di\u0107 M, et al. Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin. J Med Chem. 2012;55:1389\u2013401.","journal-title":"J Med Chem"},{"key":"1114_CR32","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1021\/jm201676t","volume":"55","author":"D Pe\u0161i\u0107","year":"2012","unstructured":"Pe\u0161i\u0107 D, Star\u010devi\u0107 K, Toplak A, Herreros E, Vidal J, Almela MJ, et al. Design, synthesis, and in vitro activity of novel 2\u2032-O-substituted 15-membered azalides. J Med Chem. 2012;55:3216\u201327.","journal-title":"J Med Chem"},{"key":"1114_CR33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1365-2958.2002.02825.x","volume":"43","author":"M Camps","year":"2002","unstructured":"Camps M, Arrizabalaga G, Boothroyd J. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol Microbiol. 2002;43:1309\u201318.","journal-title":"Mol Microbiol"},{"key":"1114_CR34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/37132","volume":"390","author":"ME Fichera","year":"1997","unstructured":"Fichera ME, Roos DS. A plastid organelle as a drug target in apicomplexan parasites. Nature. 1997;390:407\u20139.","journal-title":"Nature"},{"key":"1114_CR35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/infdis\/150.6.904","volume":"150","author":"LS Seaberg","year":"1984","unstructured":"Seaberg LS, Parquette AR, Gluzman IY, Phillips GW, Brodasky TF, Krogstad DJ. Clindamycin activity against chloroquine-resistant Plasmodium falciparum. J Infect Dis. 1984;150:904\u201311.","journal-title":"J Infect Dis"},{"key":"1114_CR36","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrmicro1265","volume":"3","author":"J Poehlsgaard","year":"2005","unstructured":"Poehlsgaard J, Douthwaite S. The bacterial ribosome as a target for antibiotics. Nat Rev Microbiol. 2005;3:870\u201381.","journal-title":"Nat Rev Microbiol"},{"key":"1114_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4269\/ajtmh.1993.49.101","volume":"49","author":"BA Gingras","year":"1993","unstructured":"Gingras BA, Jensen JB. Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. Am J Trop Med Hyg. 1993;49:101\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4269\/ajtmh.13-0474","volume":"91","author":"D Gao","year":"2014","unstructured":"Gao D, Amza A, Nassirou B, Kadri B, Sippl-Swezey N, Liu F, et al. Optimal seasonal timing of oral azithromycin for malaria. Am J Trop Med Hyg. 2014;91:936\u201342.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR39","doi-asserted-by":"crossref","unstructured":"Van Eijk AM, Terlouw DJ: Azithromycin for treating uncomplicated malaria. Cochrane Database Syst Rev. 2011;CD006688.","DOI":"10.1002\/14651858.CD006688.pub2"},{"key":"1114_CR40","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.46.8.2518-2524.2002","volume":"46","author":"C Ohrt","year":"2002","unstructured":"Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrob Agents Chemother. 2002;46:2518\u201324.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR41","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/508175","volume":"43","author":"H Noedl","year":"2006","unstructured":"Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, et al. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis. 2006;43:1264\u201371.","journal-title":"Clin Infect Dis"},{"key":"1114_CR42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.actatropica.2006.10.008","volume":"100","author":"S Nakornchai","year":"2006","unstructured":"Nakornchai S, Konthiang P. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Trop. 2006;100:185\u201391.","journal-title":"Acta Trop"},{"key":"1114_CR43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/653710","volume":"202","author":"K Thriemer","year":"2010","unstructured":"Thriemer K, Starzengruber P, Khan WA, Haque R, Marma ASP, Ley B, et al. Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial. J Infect Dis. 2010;202:392\u20138.","journal-title":"J Infect Dis"},{"key":"1114_CR44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4269\/ajtmh.2006.74.401","volume":"74","author":"RS Miller","year":"2006","unstructured":"Miller RS, Wongsrichanalai C, Buathong N, McDaniel P, Walsh DS, Knirsch C, et al. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin\u2013quinine combinations: a randomized, dose-ranging study. Am J Trop Med Hyg. 2006;74:401\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/bdrb.20027","volume":"71","author":"RL Clark","year":"2004","unstructured":"Clark RL, White TEK, A Clode S, Gaunt I, Winstanley P, Ward SA. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol. 2004;71:380\u201394.","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"1114_CR46","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/432554","volume":"192","author":"IM Hastings","year":"2005","unstructured":"Hastings IM, Ward SA. Coartem (artemether\u2013lumefantrine) in Africa: the beginning of the end? J Infect Dis. 2005;192:1303\u20134.","journal-title":"J Infect Dis"},{"key":"1114_CR47","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/clinids\/4.6.1133","volume":"4","author":"VK Dhawan","year":"1982","unstructured":"Dhawan VK, Thadepalli H. Clindamycin: a review of fifteen years of experience. Rev Infect Dis. 1982;4:1133\u201353.","journal-title":"Rev Infect Dis"},{"key":"1114_CR48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CMR.13.3.451-469.2000","volume":"13","author":"MJ Homer","year":"2000","unstructured":"Homer MJ, Aguilar-Delfin I, Telford SR, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev. 2000;13:451\u201369.","journal-title":"Clin Microbiol Rev"},{"key":"1114_CR49","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.42.5.995","volume":"42","author":"JA Fishman","year":"1998","unstructured":"Fishman JA. Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother. 1998;42:995\u20131004.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4269\/ajtmh.1975.24.369","volume":"24","author":"DF Clyde","year":"1975","unstructured":"Clyde DF, Gilman RH, McCarthy VC. Antimalarial effects of clindamycin in man. Am J Trop Med Hyg. 1975;24:369\u201370.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/23.2.275","volume":"23","author":"PG Kremsner","year":"1989","unstructured":"Kremsner PG, Zotter GM, Feldmeier H, Graninger W, Westerman RL, Rocha RM. Clindamycin treatment of falciparum malaria in Brazil. J Antimicrob Chemother. 1989;23:275\u201381.","journal-title":"J Antimicrob Chemother"},{"key":"1114_CR52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/infdis\/169.2.467","volume":"169","author":"PG Kremsner","year":"1994","unstructured":"Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis. 1994;169:467\u201370.","journal-title":"J Infect Dis"},{"key":"1114_CR53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.1974.23.565","volume":"23","author":"LH Miller","year":"1974","unstructured":"Miller LH, Glew RH, Wyler DJ, Howard WA, Collins WE, Contacos PG, et al. Evaluation of clindamycin in combination with quinine against multidrug-resistant strains of Plasmodium falciparum. Am J Trop Med Hyg. 1974;23:565\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.39.1.245","volume":"39","author":"W Metzger","year":"1995","unstructured":"Metzger W, Mordm\u00fcller B, Graninger W, Bienzle U, Kremsner PG. High efficacy of short-term quinine\u2013antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic. Antimicrob Agents Chemother. 1995;39:245\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR55","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","volume":"41","author":"NJ White","year":"1997","unstructured":"White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 1997;41:1413\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR56","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4269\/ajtmh.1993.49.650","volume":"49","author":"PG Kremsner","year":"1993","unstructured":"Kremsner PG, Winkler S, Brandts C, Graninger W, Bienzle U. Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg. 1993;49:650\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1365-3156.1997.d01-411.x","volume":"2","author":"M Vaillant","year":"1997","unstructured":"Vaillant M, Millet P, Luty A, Tshopamba P, Lekoulou F, Mayombo J, et al. Therapeutic efficacy of clindamycin in combination with quinine for treating uncomplicated malaria in a village dispensary in Gabon. Trop Med Int Health. 1997;2:917\u20139.","journal-title":"Trop Med Int Health"},{"key":"1114_CR58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(02)11860-5","volume":"360","author":"MA Missinou","year":"2002","unstructured":"Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui P-B, et al. Fosmidomycin for malaria. Lancet. 2002;360:1941\u20132.","journal-title":"Lancet"},{"key":"1114_CR59","unstructured":"World Health Organization. Guidelines for the treatment of malaria. 2nd ed. 2010."},{"key":"1114_CR60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","volume":"356","author":"F Nosten","year":"2000","unstructured":"Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000;356:297\u2013302.","journal-title":"Lancet"},{"key":"1114_CR61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","volume":"2","author":"C Wongsrichanalai","year":"2002","unstructured":"Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002;2:209\u201318.","journal-title":"Lancet Infect Dis"},{"key":"1114_CR62","first-page":"301","volume":"41","author":"NJ White","year":"1999","unstructured":"White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia. 1999;41:301\u20138.","journal-title":"Parassitologia"},{"key":"1114_CR63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S0037-86822003000200005","volume":"36","author":"M das GC Alecrim","year":"2003","unstructured":"Alecrim M das GC, Carvalho LM, Andrade SD, Arcanjo ARL, Alexandre MA, Alecrim WD. Treatment of children with malaria Plasmodium falciparum with derivatives artemisinin. Rev Soc Bras Med Trop. 2003;36:223\u20136.","journal-title":"Rev Soc Bras Med Trop"},{"key":"1114_CR64","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkl563","volume":"59","author":"L Vivas","year":"2007","unstructured":"Vivas L, Rattray L, Stewart LB, Robinson BL, Fugmann B, Haynes RK, et al. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo. J Antimicrob Chemother. 2007;59:658\u201365.","journal-title":"J Antimicrob Chemother"},{"key":"1114_CR65","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/324626","volume":"34","author":"R Leclercq","year":"2002","unstructured":"Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34:482\u201392.","journal-title":"Clin Infect Dis"},{"key":"1114_CR66","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1128\/AAC.43.12.2823","volume":"43","author":"MC Roberts","year":"1999","unstructured":"Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother. 1999;43:2823\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR67","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","volume":"39","author":"B Weisblum","year":"1995","unstructured":"Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 1995;39:577\u201385.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","volume":"45","author":"B Vester","year":"2001","unstructured":"Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother. 2001;45:1\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR69","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1054\/drup.2000.0175","volume":"3","author":"P Zhong","year":"2000","unstructured":"Zhong P, Shortridge VD. The role of efflux in macrolide resistance. Drug Resist Updat. 2000;3:325\u20139.","journal-title":"Drug Resist Updat"},{"key":"1114_CR70","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1099\/00221287-143-7-2117","volume":"143","author":"KE Hagman","year":"1997","unstructured":"Hagman KE, Lucas CE, Balthazar JT, Snyder L, Nilles M, Judd RC, et al. The MtrD protein of Neisseria gonorrhoeae is a member of the resistance\/nodulation\/division protein family constituting part of an efflux system. Microbiology. 1997;143:2117\u201325.","journal-title":"Microbiology"},{"key":"1114_CR71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0378-1119(92)90545-Z","volume":"115","author":"B Schoner","year":"1992","unstructured":"Schoner B, Geistlich M, Rosteck P, Rao RN, Seno E, Reynolds P, et al. Sequence similarity between macrolide-resistance determinants and ATP-binding transport proteins. Gene. 1992;115:93\u20136.","journal-title":"Gene"},{"key":"1114_CR72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1574-6968.1998.tb13232.x","volume":"167","author":"M Matsuoka","year":"1998","unstructured":"Matsuoka M, Endou K, Kobayashi H, Inoue M, Nakajima Y. A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol Lett. 1998;167:221\u20137.","journal-title":"FEMS Microbiol Lett"},{"key":"1114_CR73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1568005043340696","volume":"4","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Sasaki T. Inactivation of macrolides by producers and pathogens. Curr Drug Targets Infect Disord. 2004;4:217\u201340.","journal-title":"Curr Drug Targets Infect Disord"},{"key":"1114_CR74","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkm008","volume":"59","author":"P L\u00fcthje","year":"2007","unstructured":"L\u00fcthje P, von K\u00f6ckritz-Blickwede M, Schwarz S. Identification and characterization of nine novel types of small staphylococcal plasmids carrying the lincosamide nucleotidyltransferase gene lnu(A). J Antimicrob Chemother. 2007;59:600\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"1114_CR75","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0014-4894(76)90073-4","volume":"40","author":"RL Jacobs","year":"1976","unstructured":"Jacobs RL, Koontz LC. Plasmodium berghei: development of resistance to clindamycin and minocycline in mice. Exp Parasitol. 1976;40:116\u201323.","journal-title":"Exp Parasitol"},{"key":"1114_CR76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0014-4894(79)90100-0","volume":"48","author":"LC Koontz","year":"1979","unstructured":"Koontz LC, Jacobs RL, Lummis WL, Miller LH. Plasmodium berghei: uptake of clindamycin and its metabolites by mouse erythrocytes with clindamycin-sensitive and clindamycin-resistant parasites. Exp Parasitol. 1979;48:206\u201312.","journal-title":"Exp Parasitol"},{"key":"1114_CR77","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/nar\/21.5.1067","volume":"21","author":"MJ Gardner","year":"1993","unstructured":"Gardner MJ, Feagin JE, Moore DJ, Rangachari K, Williamson DH, Wilson RJ. Sequence and organization of large subunit rRNA genes from the extrachromosomal 35\u00a0kb circular DNA of the malaria parasite Plasmodium falciparum. Nucleic Acids Res. 1993;21:1067\u201371.","journal-title":"Nucleic Acids Res"},{"key":"1114_CR78","first-page":"522","volume":"27","author":"K Na-Bangchang","year":"1996","unstructured":"Na-Bangchang K, Kanda T, Tipawangso P, Thanavibul A, Suprakob K, Ibrahim M, et al. Activity of artemether\u2013azithromycin versus artemether\u2013doxycycline in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health. 1996;27:522\u20135.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"1114_CR79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/bmj.2.5961.12","volume":"2","author":"AP Hall","year":"1975","unstructured":"Hall AP, Doberstyn EB, Nanokorn A, Sonkom P. Falciparum malaria semi-resistant to clindamycin. BMJ. 1975;2:12\u20134.","journal-title":"BMJ"},{"key":"1114_CR80","first-page":"86","volume":"23","author":"M das G Alecrim","year":"1981","unstructured":"Alecrim M das G, Dourado H, Alecrim W, Albuquerque BC, Wanssa E, Wanssa Mdo C. Treatment of malaria (P. falciparum) with clindamycin. Rev Inst Med Trop Sao Paulo. 1981;23:86\u201391.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1114_CR81","first-page":"40","volume":"24","author":"WD Alecrim","year":"1982","unstructured":"Alecrim WD, Albuquerque BC, Alecrim MG, Dourado H. Treatment of malaria (P. falciparum) with clindamycin. II\u2014dosage schedule for 5 days. Rev Inst Med Trop Sao Paulo. 1982;24:40\u20133.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1114_CR82","first-page":"70","volume":"24","author":"DG Rivera","year":"1982","unstructured":"Rivera DG, Cabrera BD, Lara NT. Treatment of falciparum malaria with clindamycin. Rev Inst Med Trop Sao Paulo. 1982;24:70\u20135.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1114_CR83","first-page":"62","volume":"24","author":"BD Cabrera","year":"1982","unstructured":"Cabrera BD, Rivera DG, Lara NT. Study on clindamycin in the treatment of falciparum malaria. Rev Inst Med Trop Sao Paulo. 1982;24:62\u20139.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1114_CR84","first-page":"15","volume":"9","author":"A Restrepo","year":"1984","unstructured":"Restrepo A, Restrepo M, Baena C, Mejia B, Sossa P, Salazar M. Tratamiento con clindamicina de la malaria por falciparum resistente. Acta Med Col. 1984;9:15\u201321.","journal-title":"Acta Med Col"},{"key":"1114_CR85","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4269\/ajtmh.1985.34.1065","volume":"34","author":"ES Wakeel El","year":"1985","unstructured":"El Wakeel ES, Homeida MM, Ali HM, Geary TG, Jensen JB. Clindamycin for the treatment of falciparum malaria in Sudan. Am J Trop Med Hyg. 1985;34:1065\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"1114_CR86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/S0037-86821988000300005","volume":"21","author":"DA Meira","year":"1988","unstructured":"Meira DA, Pereira PC, Marcondes-Machado J, Mendes RP, Barraviera B, Pirola JA, et al. Malaria in Humaita County, State of Amazonas, Brazil. XIX\u2014Evaluation of clindamycin for the treatment of patients with Plasmodium falciparum infection. Rev Soc Bras Med Trop. 1988;21:123\u20139.","journal-title":"Rev Soc Bras Med Trop"},{"key":"1114_CR87","first-page":"397","volume":"21","author":"NP Salazar","year":"1990","unstructured":"Salazar NP, Saniel MC, Estoque MH, Talao FA, Bustos DG, Palogan LP, et al. Oral clindamycin in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health. 1990;21:397\u2013403.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"1114_CR88","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0011-393X(05)80533-8","volume":"55","author":"S Oemijati","year":"1994","unstructured":"Oemijati S, Pribadi W, Wartati K, Arbani P, Suprijanto S, Rasisi R, Zambrano D. Treatment of chloroquine-resistant Plasmodium falciparum infections with clindamycin hydrochloride in Dili, East Timor. Indonesia. Curr Ther Res Clin Exp. 1994;55:468\u201379.","journal-title":"Indonesia. Curr Ther Res Clin Exp"},{"key":"1114_CR89","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/36.4.723","volume":"36","author":"W Metzger","year":"1995","unstructured":"Metzger W, Mordm\u00fcller B, Graninger W, Bienzle U, Kremsner PG. Sulfadoxine\/pyrimethamine or chloroquine\/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria. J Antimicrob Chemother. 1995;36:723\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"1114_CR90","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.39.7.1603","volume":"39","author":"PG Kremsner","year":"1995","unstructured":"Kremsner PG, Radloff P, Metzger W, Wildling E, Mordm\u00fcller B, Philipps J, et al. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother. 1995;39:1603\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR91","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1128\/AAC.45.3.932-935.2001","volume":"45","author":"P Parola","year":"2001","unstructured":"Parola P, Ranque S, Badiaga S, Niang M, Blin O, Charbit JJ, et al. Controlled trial of 3-day quinine\u2013clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics. Antimicrob Agents Chemother. 2001;45:932\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1114_CR92","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.44.9.2395-2398.2000","volume":"44","author":"S Pukrittayakamee","year":"2000","unstructured":"Pukrittayakamee S, Chantra A, Vanijanonta S, Clemens R, Looareesuwan S, White NJ. Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob Agents Chemother. 2000;44:2395\u20138.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1114-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T13:57:11Z","timestamp":1567605431000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/15\/1\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1114"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1114-z","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]},"article-number":"85"}}